The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment - Cotter, G; Dittrich, H; Weatherley, B (J Cardiac Failure, 2008)